Pyxis Oncology, Inc (PYXS) insider trading

Every open-market stock purchase and sale by Pyxis Oncology, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: Pamela Ann Connealy (CFO), $163K, 22 months ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $1.69 on Jun 7, 2026.

Recent PYXS insider trades

DateInsiderTradeValue
Mar 24, 2026Freda C Lewis-Hall (Insider)Bought (not open market)—
Mar 24, 2026Darren S Cline (Insider)Bought (not open market)—
Mar 24, 2026Jitendra Wadhane (Insider)Bought (not open market)—
Mar 24, 2026John L Flavin (Insider)Bought (not open market)—
Mar 24, 2026Jakob Dupont (Insider)Bought (not open market)—
Mar 24, 2026Jitendra Wadhane (Insider)Bought (not open market)—
Mar 24, 2026Rachel Humphrey (Insider)Bought (not open market)—
Mar 24, 2026Santhosh Palani (Insider)Bought (not open market)—
Mar 24, 2026Michael A Metzger (Insider)Bought (not open market)—
Feb 3, 2026Thomas Civik (CEO)Bought (not open market)—

Who's trading PYXS

Get free alerts when an insider at Pyxis Oncology, Inc files a new trade →